Intraocular Pressure and Anti-Vascular Endothelial Growth Factor Injections

Affiliations

¹ Department of Ophthalmology, Rush University Medical Center, Chicago, Illinois; Illinois Retina Associates, S.C., Chicago, Illinois. Electronic address: mmaccumber@illinoisretina.com.

Editorial

Mathew W MacCumber. Ophthalmol Retina. 2020 Sep.

. 2020 Sep;4(9):859-860.

doi: 10.1016/j.oret.2020.06.025.

¹ Department of Ophthalmology, Rush University Medical Center, Chicago, Illinois; Illinois Retina Associates, S.C., Chicago, Illinois. Electronic address: mmaccumber@illinoisretina.com.

No abstract available

Comment on

Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Wolff B, Essex R, Young S, Hunt A, Gemmy Cheung CM, Arnold JJ, Barthelmes D, Creuzot-Garcher C, Gillies M; Fight Retinal Blindness! Study Group. Gabrielle PH, et al. Ophthalmol Retina. 2020 Sep;4(9):861-870. doi: 10.1016/j.oret.2020.06.020. Epub 2020 Jun 20. Ophthalmol Retina. 2020. PMID: 32574830